Skip to main content

As therapies advance and patients are living longer, brain metastases and leptomeningeal disease (LMD) have become a growing concern for individuals diagnosed with lung cancer. Identification and treatment of these conditions are developing to meet this serious unmet need. Join Laura Alder, MD and Trey Mullikin, MD from Duke Center for Brain & Spine Metastasis, who will lead a comprehensive discussion regarding the identification and treatment for these conditions.

Laura Alder, MD

Program Agenda

Welcome & Introduction

Brain Metastases: What Are They?

Treatment Options: A Multidisciplinary Approach to Brain Metastases

Leptomeningeal Disease: What Is It?

Treatment Options: A Multidisciplinary Approach to LMD

Trey Mullikin, MD

Laura Alder, MD

Trey Mullikin, MD

Program Agenda

Welcome & Introduction

Brain Metastases: What Are They?

Treatment Options: A Multidisciplinary Approach to Brain Metastases

Leptomeningeal Disease: What Is It?

Treatment Options: A Multidisciplinary Approach to LMD

Allison Vuong, Patient Advocate

Also Featuring Allison Vuong, Patient Advocate

“Caring for my mom has been a journey defined by a wide spectrum of emotions—periods of sadness, anger, frustration, and hopelessness, but also profound joy, gratitude, love, beauty, and hope. After a lobectomy in 2016, we thought she was free of disease until dull headaches led to the devastating discovery of multiple brain metastases and leptomeningeal disease in 2018. For our family, it has been absolutely critical to be our own advocates and work in partnership with our doctors to get the best care and treatment available today.” – Allison Vuong

Disclaimer: The views expressed in this presentation are those of the speaker(s) and do not necessarily reflect the official policy or position of Duke Cancer Center, Duke Health, Duke University, or EGFR Resisters. This presentation is for educational purposes only and does not constitute medical advice. Please consult your healthcare provider for personalized medical guidance.